IMVT
ImmunovantANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The post-print bull case is that the market is willing to look through the widened loss because IMVT-1402 produced strong open-label D2T RA activity, no new safety signals, and enough cash to fund announced indications through a potential GD launch. Stifel was reported to reiterate Buy with a $49 target after the release, reinforcing that some analysts see the data as supporting a higher valuation.
Posture
Constructive
Lead driver
Momentum
What changed
3 setup hits (3d) with net bullish as of 2026-06-02.
What can break
Batoclimab discontinuation leaves IMVT-1402 as the dominant strategic driver, increasing concentration risk.
Momentum
87
Value
41
Sentiment
66
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $37.00 · Bull $52.00 · Bear $18.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-23 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Bullish
Target $41.13
Why
Momentum87 · Δ7d +3.8
Value41 · Δ7d +0.1
Sentiment66 · Δ7d +7.4
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
87
34% active weight
Current posture
7d trendFlat
Δ7d
+3.8
Δ21d
+9.2
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
66
33% active weight
Current posture
7d trendImproving
Δ7d
+7.4
Δ21d
+11.0
Why this grade
Composite grade A. Momentum 87.0 / Value 41.1 / Sentiment 65.5
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$6.75B
Beta
0.54
Shares Out
202.68M
P/E (TTM) · Derived
-12.2
P/S (TTM)
-
P/FCF (TTM) · Derived
-12.70
Rev YoY
-
EPS YoY
+2.2%
Gross Margin
-
Op Margin
-
Net Debt
-$713.97M
Current Ratio
9.07
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology